Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12

International Journal of Cancer

Volumn 108, Issue 1, 2004, Pages 15-22

  Jaeger, Erich B ^a   Chekmareva, Marina A ^a   Tennant, Thelma R ^a   Luu, Hue H ^a   Hickson, Jonathan A ^a   Chen, Stephen L ^a   Samant, Rajeev S ^c   Sokoloff, Mitchell H ^b   Rinker Schaeffer, Carrie W ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Chicago   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Human chromosome 12; Metastasis suppression; Prostate cancer

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL TRAIT; CANCER INHIBITION; CHROMOSOME 12; CONTROLLED STUDY; GENE LOCATION; GENE SEQUENCE; GENETIC TRAIT; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOBLOTTING; MALE; METASTASIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE TAGGED SITE; SUPPRESSOR GENE;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RATS; TUMOR CELLS, CULTURED;

EID: 0345256407     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11483     Document Type: Article

References (33)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-83,
3. Hussain A, Dawson N. Management of advanced/metastatic prostate cancer. Oncology 2000;14:1677-88.
4. Hankey BF, Feuer BF, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst 1999;91:1017-24.
5. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol 1997;158:1427-30.
6. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1000 consecutive cases. J Urol 2002;167:528-34.
7. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-7.
8. Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999;281:1598-604.
9. Zagars GK, Pollack A. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology 1995; 45:476-83.
10. Gopalkrishnan RV, Kang DC, Fisher PB. Molecular markers and determinants of prostate cancer metastasis. J Cell Physiol 2001;189: 245-56.
11. Putzi MJ, De Marzo AM. Prostate pathology: histologic and molecular perspectives. Hematol Oncol Clin North Am 2001;15:407-21.
12. Pettaway CA. Prognostic markers in clinically localized prostate cancer. Tech Urol 1998;4:35-42.
13. Isaacs JT. Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1997;150:1511-21.
14. Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003;169:1122-33.
15. Cher ML. Mechanisms governing bone metastasis in prostate cancer. Curr Opin Urol 2001;11:483-.
16. Jaeger EB, Samant RS, Rinker-Schaeffer CW. Metastasis suppression in prostate cancer. Cancer Metastasis Rev 2001;20:279-86.
17. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3:55-63.
18. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 2000;92:1717-030.
19. Chekmareva MA, Kadkhodaian MM, Hollowell CMP, Kim H, Yoshida BA, Luu HH, Stadler WM, Rinker-Schaeffer CW. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res 1998;58:4963-9.
20. Goldberg SF, Harms JF, Quon K, Welch DR. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin Exp Metastasis 1999;17:601-7.
21. Luu HH, Zagaja GP, Dubauskas Z, Chen SL, Smith RC, Watabe K, Ichikawa Y, Ichikawa T, Davis EM, LeBeau MM, Rinker-Schaeffer CW. Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res 1998:5:3561-5.
22. Ichikawa T, Kyprianou N, Isaacs JT. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. Cancer Res 1990;50:6349-57.
23. Chekmareva MA, Hollowell CMP, Smith RC, Davis EM, LeBeau MM, Rinker-Schaeffer CW. Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate 1997;33: 271-80.
24. Dubauskas Z, Beck TP, Chmura SJ, Kovar DA, Kadkhodaian MM, Shrivastav M, Chung T, Stadler WM, Rinker-Schaeffer CW. Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential. Clin Cancer Res 1998;4:2391-8.
25. Welch DR. Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 1997;15:272-306.
26. Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM. The p400 complex is an essential E1A transformation target. Cell 2001;106:297-307.
27. Sinclair DA, Clegg NJ, Antonchuk J, Milne TA, Stankunas K, Ruse C, Grigliatti TA, Kassis JA, Brock HW. Enhancer of Polycomb is a suppressor of position-effect variegation in Drosophila melanogaster. Genetics 1998;148:211-20.
28. Tada Y, O-Wang J, Takenaga K, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Expression of the TNF-alpha gene on mouse lung carcinoma cells suppresses spontaneous lung metastasis without affecting tumorigenicity. Oncol Rep 2002;9:585-8.
29. Akiyama SK, Olden K, Yamada KM. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 1995;14:173-89.
30. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12:89-96.
31. Christiano AP, Yoshida BA, Dubauskas Z, Sokoloff MH, Rinker-Schaeffer CW. Development of markers of prostate cancer: review and perspective. Urol Oncol 2000;5:217-23.
32. Rinker-Schaeffer CW, Welch DR, Sokoloff MH. Defining the biologic role of genes that regulate prostate cancer metastasis. Curr Opin Urol 2000;10:397-401.
33. Hendrix MJ. Editorial: potential clinical use of exploiting metastasis suppressor genes to regulate prostatic cancer. J Urol 2003;169:1134.